What is mPharma?
Founded in 2013 and headquartered in Ghana, mPharma operates as a sophisticated health-tech platform designed to democratize access to quality medication and essential medical services. The company functions as a comprehensive network of community pharmacies that serve as decentralized mini-hospitals. By integrating diagnostic capabilities, telehealth consultations, and streamlined supply chain management, mPharma addresses the systemic inefficiencies that have historically hindered healthcare delivery in Africa. Its market position is defined by a dual focus on affordability and accessibility, positioning the firm as a primary healthcare partner for millions of individuals who previously lacked consistent access to professional medical oversight.
How much funding has mPharma raised?
mPharma has raised a total of $68.3M across 5 funding rounds:
Series A
$6.6M
Series B
$9.7M
Series C
$17M
Series D
$30M
Debt
$5M
Series A (2017): $6.6M with participation from Social Capital, 4DX Ventures, and Golden Palm Investments
Series B (2019): $9.7M led by Unbound, Cem Garih, and Novastar Ventures
Series C (2020): $17M supported by CDC Group Plc
Series D (2022): $30M featuring Unbound, JAM Fund, and Lux Capital
Debt (2022): $5M backed by Citi
Key Investors in mPharma
Social Capital
A venture capital firm dedicated to solving complex global problems by empowering entrepreneurs who aim to improve lives through technology and innovation.
4DX Ventures
An early-stage venture capital firm specifically focused on supporting high-growth technology companies within the African market.
Golden Palm Investments
An investment holding and advisory firm that targets high-growth technology opportunities across fundamental industries in Africa to drive economic development.
What's next for mPharma?
With the successful closure of its latest funding round, mPharma is poised to accelerate its expansion strategy, focusing on deepening its footprint in existing markets while exploring new territories. The capital will likely be deployed to enhance its digital health infrastructure, optimize inventory management through data-driven analytics, and expand its network of partner pharmacies. As the company matures, the focus will shift toward long-term sustainability and the integration of more advanced medical services, ensuring that its model remains resilient against the complex logistical challenges inherent in the African healthcare sector. This strategic growth phase is expected to solidify mPharma's status as a cornerstone of the continent's evolving digital health ecosystem.
See full mPharma company page
